Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Human ADCY7 Protein, GST-tagged

Cat.No. : ADCY7-331H
Product Overview : Human ADCY7 partial ORF ( NP_001105, 197 a.a. - 277 a.a.) recombinant protein with GST-tag at N-terminal.
  • Specification
  • Gene Information
  • Related Products
Description : This gene encodes a membrane-bound adenylate cyclase that catalyses the formation of cyclic AMP from ATP and is inhibitable by calcium. The product of this gene is a member of the adenylyl cyclase class-4/guanylyl cyclase enzyme family that is characterized by the presence of twelve membrane-spanning domains in its sequences. Several transcript variants have been observed for this gene, but the full-length natures of only two have been determined so far. [provided by RefSeq, Oct 2013]
Source : Wheat Germ
Species : Human
Tag : GST
Molecular Mass : 34.65 kDa
AA Sequence : HKHQMQDASRDLFTYTVKCIQIRRK LRIEKRQQENLLLSVLPAHISMGMK LAIIERLKEHGDRRCMPDNNFHSLY VKRHQN
Applications : Enzyme-linked Immunoabsorbent Assay
Western Blot (Recombinant protein)
Antibody Production
Protein Array
Notes : Best use within three months from the date of receipt of this protein.
Storage : Store at -80 centigrade. Aliquot to avoid repeated freezing and thawing.
Storage Buffer : 50 mM Tris-HCI, 10 mM reduced Glutathione, pH=8.0 in the elution buffer.
Gene Name : ADCY7 adenylate cyclase 7 [ Homo sapiens ]
Official Symbol : ADCY7
Synonyms : ADCY7; adenylate cyclase 7; adenylate cyclase type 7; AC7; KIAA0037; adenylyl cyclase 7; ATP pyrophosphate-lyase 7; adenylate cyclase type VII; FLJ36387;
Gene ID : 113
mRNA Refseq : NM_001114
Protein Refseq : NP_001105
MIM : 600385
UniProt ID : P51828

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (15)

Ask a question
What role does ADCY7 play in the immune system? 08/25/2022

ADCY7 is known to play a critical role in the immune system by regulating the production of anti-inflammatory cytokines and other immune molecules. Studies have shown that ADCY7-deficient mice have impaired T-cell responses and are more susceptible to infections, suggesting that ADCY7 is important for maintaining a healthy immune system.

What are some challenges associated with developing drugs that target ADCY7? 04/03/2022

One of the challenges associated with developing drugs that target ADCY7 is that it is a relatively complex protein with multiple domains and regulatory mechanisms that can affect its activity. Additionally, there is the potential for off-target effects and unintended consequences of modulating ADCY7 activity. Furthermore, it can be difficult to target ADCY7 specifically in certain cells or tissues without affecting other cells or tissues.

How can ADCY7 protein be used in cancer treatment? 01/16/2022

ADCY7 is being explored as a potential target in cancer treatment due to its role in regulating immune responses and inflammation. Modulating ADCY7 activity may help to enhance antitumor immune responses and improve the efficacy of current cancer treatments.

Is there potential for ADCY7-based therapies to be used in combination with other treatments? 08/07/2021

Yes, there is potential for ADCY7-based therapies to be used in combination with other treatments. For example, ADCY7 activators may be used in combination with chemotherapy or radiation therapy to enhance their anticancer effects. Additionally, ADCY7 inhibitors may be used in combination with immunotherapy to enhance T-cell responses in cancer patients.

Is there a link between ADCY7 and diabetes? 07/03/2021

There is evidence to suggest that ADCY7 may play a role in the development of type 2 diabetes. Studies have shown that ADCY7-deficient mice have impaired insulin secretion and glucose homeostasis. Additionally, some genetic variants of ADCY7 have been linked to an increased risk of developing type 2 diabetes in humans.

Are there any ongoing clinical trials involving drugs that target ADCY7? 05/19/2020

To our knowledge, there are currently no ongoing or planned clinical trials specifically targeting ADCY7. However, there are several clinical trials ongoing or planned for drugs that indirectly modulate cAMP signaling pathways for the treatment of various diseases and conditions, including cancer and cardiovascular disease. Some of these drugs may have an effect on ADCY7 activity.

How can researchers better understand the role of ADCY7 in disease? 01/27/2020

Researchers can use a variety of techniques to better understand the role of ADCY7 in disease. These include genetic manipulation of ADCY7 expression or activity in animal models, analysis of human genetic variants associated with disease, and bioinformatics analysis of ADCY7 signaling pathways in disease-related tissues. Additionally, the use of high-throughput screening methods to identify compounds that selectively modulate ADCY7 activity can help to identify potential therapeutic targets.

Are there any drugs currently available that target ADCY7? 01/18/2020

At present, there are no drugs specifically targeting ADCY7 that are approved for clinical use. However, there are several compounds that indirectly modulate cAMP signaling pathways, which are downstream of ADCY7 activity. For example, forskolin is a naturally occurring compound that activates all known types of ADCY, including ADCY7, leading to increased cAMP production.

Can ADCY7 protein be used as a diagnostic tool? 10/23/2018

ADCY7 protein is not typically used as a direct diagnostic tool. However, measuring ADCY7 expression levels or genetic variants associated with ADCY7 may be useful in predicting disease outcomes and identifying patients who may benefit from certain treatments.

Can ADCY7 protein be used to treat diabetes? 07/27/2018

ADCY7 is being studied as a potential therapeutic target in diabetes due to its role in regulating insulin secretion and glucose homeostasis. Activating or inhibiting ADCY7 may help to improve insulin sensitivity and glycemic control in diabetic patients.

Is it possible to supplement ADCY7 protein for therapeutic purposes? 01/24/2018

It is currently not possible to supplement ADCY7 protein for therapeutic purposes. However, the development of ADCY7 agonists or inhibitors may help to modulate ADCY7 activity for therapeutic benefit.

Are there any drugs that target ADCY7 protein? 03/19/2017

There are currently no drugs that specifically target ADCY7 protein. However, compounds that modulate ADCY7 activity are being developed and tested for their therapeutic potential.

Can ADCY7 be used to predict patient outcomes in certain diseases? 10/15/2016

There is some evidence to suggest that ADCY7 expression levels may be predictive of patient outcomes in certain diseases. For example, higher levels of ADCY7 have been associated with better outcomes in patients with breast cancer and lower levels of ADCY7 have been associated with worse outcomes in patients with heart failure.

How can ADCY7 be targeted specifically in certain cells or tissues? 09/06/2016

There are several strategies for targeting ADCY7 specifically in certain cells or tissues. One approach is to use cell-specific promoters to drive expression of an ADCY7 inhibitor or activator. Another approach is to use targeted gene editing techniques, such as CRISPR-Cas9, to specifically modify the ADCY7 gene in certain cells or tissues. Moreover, targeted drug delivery systems, such as nanoparticles or liposomes, can be used to specifically deliver drugs or inhibitors to certain cells or tissues.

What are some potential therapeutic applications of the ADCY7 protein? 02/10/2015

The ADCY7 protein has potential therapeutic applications in the treatment of a wide variety of diseases and conditions, including neurodegenerative disorders, cancer, cardiovascular disease, and metabolic disorders. As an enzyme that converts ATP to cAMP, it plays a critical role in many cellular signaling pathways and is therefore a key target for therapeutic interventions.

Customer Reviews (0)

Write a review

Ask a Question for All ADCY7 Products

Required fields are marked with *

My Review for All ADCY7 Products

Required fields are marked with *

0

Inquiry Basket

cartIcon
logo

FOLLOW US

Terms and Conditions        Privacy Policy

Copyright © 2024 Creative BioMart. All Rights Reserved.

Contact Us

  • /

Stay Updated on the Latest Bioscience Trends